New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

SILIQ (brodalumab) injection

This specialty medication is authorized and manufactured internationally and is not registered or commercially distributed for retail sale in India. To verify patient eligibility, check international supply availability, or understand the regulatory logistics and documentation process: Call our Compliance Desk at 9891296838 or Email your Inquiry query@southdelhipharma.com.

Siliq is a brand-name prescription medication. It’s used to treat moderate to severe plaque psoriasis in adults. Plaque psoriasis is one of many kinds of psoriasis.

Brand Name: SILIQ (brodalumab) – On Request
Generic Name: brodalumab
Strength: • Injection: 210 mg/1.5 mL solution in a single-dose prefilled syringe
Manufacturer: Valeant Pharmaceuticals International, Inc.
Approved By: EMA, USFDA
Price: On Request

Source Details: Patient Information

SILIQ (brodalumab), a FDA approved prescription medicine can be accessed in India and other part of countries. South Delhi Pharma can facilitate the supply on request under Named Patient Program by fulfilling the legal requirement (if applicable) on behalf patient. Share your mobile number and email ID to get “brodalumab” cost price in India.

Category
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

South Delhi Pharma is dedicated to facilitating access to critical, globally approved pharmaceutical therapies tailored to individual patient needs. Established in 1996, It has built a trusted reputation for assisting patients and healthcare institutions in navigating the regulatory frameworks required to securely source high-quality, international life-saving medications.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

This is an inquiry and facilitation request form. Submission does not constitute a sale, purchase order, or guarantee of medicine availability.

Description

In February 2017, it received US FDA approval to treat moderate to severe plaque psoriasis in people who have not improved with other treatments.

SILIQ™ (brodalumab) injection, for subcutaneous use Initial U.S. Approval: 2017

See full prescribing information for SILIQ.

On request get access to SILIQ (brodalumab) injection In India.

Brand Name “SILIQ” or Generic Name “brodalumab” can be imported for personal use under “Named Patient Program” treatment in Delhi, Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Jaipur, Aurangabad, Pune, Bangalore, Hyderabad, Chennai, Visakhapatnam, Coimbatore, Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu, Telangana, India. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or  you can call at 9891296838 or WhatsApp at 9891296838

Required Documents

Required Documentation for Compliance:

To legally purchase and import medicines for patient use in compliance with regulations, authorized suppliers typically require:

  1. A valid, original prescription issued by a registered medical oncologist.
  2. Supporting diagnostic or pathology reports.
  3. Valid patient identification proof and adherence to local personal import and customs guidelines.

Disclaimer

Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.

All Trademarks and Brands that appear on the website belong to their respective owners and South Delhi Pharma does not lay any claim on them we only provide Information. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

Global Network

South Delhi Pharma, Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Specialty Pharmaceutical drugs. Having more than 25 years of experience. Supplying innovator and generic anti cancer products at the most competitive prices. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.

Get Access In India

Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India.

Get Access In Overseas

Besides India, we have been able to cater medicines request coming from East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan. North America – Mexico. South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia. African Countries – Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. Europe, USA, China, Australia, ASEAN countries and Latin American countries.

Related Products